| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.001 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |